Clinical trials
Phase 2 Colitis, Ulcerative trials in China
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
26 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2015 | 1 |
| 2019 | 2 |
| 2021 | 2 |
| 2022 | 3 |
| 2023 | 1 |
| 2024 | 3 |
| 2025 | 7 |
| 2026 | 7 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Recruiting | 10 |
| Active, not recruiting | 7 |
| Completed | 4 |
| Terminated | 3 |
| Not yet recruiting | 1 |
| Unknown status | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Sanofi | 4 |
| Eli Lilly and Company | 3 |
| Genentech, Inc. | 2 |
| Janssen Research & Development, LLC | 2 |
| Takeda | 2 |
| Bristol-Myers Squibb | 1 |
| First Affiliated Hospital of Kunming Medical University | 1 |
| Haisco Pharmaceutical Group Co., Ltd. | 1 |
| InSilico Medicine Hong Kong Limited | 1 |
| Innovent Biologics (Suzhou) Co. Ltd. | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Colitis, Ulcerative | 26 |
| Crohn Disease | 5 |
| Inflammatory Bowel Diseases | 5 |
| Colitis | 1 |
| Gastrointestinal Diseases | 1 |
Trials
Showing 1 to 25 of 26. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.